ScholarLens Back to search
2010•JAMARequires access

As Use of Foreign Drug Trials Grows, FDA Oversight May Not Be Keeping Up

Mike Mitka

Open publisher page 0 citations

Abstract

The increasing reliance on foreign clinical trials for testing new drugs has led to concerns about the ability of the US Food and Drug Administration (FDA) to monitor such research, according to a US government report.

About this research paper

What this paper is about

The increasing reliance on foreign clinical trials for testing new drugs has led to concerns about the ability of the US Food and Drug Administration (FDA) to monitor such research, according to a US government report.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The increasing reliance on foreign clinical trials for testing new drugs has led to concerns about the ability of the US Food and Drug Administration (FDA) to monitor such research, according to a US government report.

Key concepts: Medicine, Food and drug administration, Clinical trial, Drug, Clinical research, Drug trial, Government (linguistics), Drug approval

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
As Use of Foreign Drug Trials Grows, FDA Oversight May Not Be Keeping Up — Research Paper | ScholarLens